Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.470
+0.170 (13.08%)
At close: Dec 31, 2025, 4:00 PM EST
1.436
-0.034 (-2.29%)
After-hours: Dec 31, 2025, 7:54 PM EST
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $135.06 million as of December 31, 2025. Its market cap has increased by 25.06% in one year.
Market Cap
135.06M
Enterprise Value
58.26M
1-Year Change
25.06%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $135.06M, an increase of 164.68%. That is a compound annual growth rate of 26.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 119.44M | 26.81% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.31B |
| Johnson & Johnson | 498.12B |
| AbbVie | 405.42B |
| UnitedHealth Group | 300.21B |
| AstraZeneca | 288.12B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.56B |
| Novo Nordisk | 227.63B |